Defense contractor Leidos (NYSE:LDOS) reported Q4 CY2025 sales of $4.21 billion, missing analyst expectations by 2.5% and representing a 3.6% year-on-year decline. Despite the revenue miss, the company’s adjusted EPS of $2.76 beat estimates by 5.9%, and its adjusted EBITDA also surpassed expectations. Leidos’s backlog grew 12.5% year-on-year to $49 billion, indicating future potential demand, though revenue growth has slowed recently.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Leidos (NYSE:LDOS) Misses Q4 CY2025 Sales Expectations
Defense contractor Leidos (NYSE:LDOS) reported Q4 CY2025 sales of $4.21 billion, missing analyst expectations by 2.5% and representing a 3.6% year-on-year decline. Despite the revenue miss, the company’s adjusted EPS of $2.76 beat estimates by 5.9%, and its adjusted EBITDA also surpassed expectations. Leidos’s backlog grew 12.5% year-on-year to $49 billion, indicating future potential demand, though revenue growth has slowed recently.